BrandyReneMatthewsMDFAAN

Neurology • Indianapolis, IN

Neurodegenerative, Dementia & Geriatrics

Sr. Medical Advisor, Global Medical Affairs, Alzheimer's Disease Platform, Eli Lilly & Co.; Volunteer Associate Professor of Clinical Neurology, Indiana University School of Medicine

Join to view full profile

Dr. Matthews is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Matthews' full profile

Already have an account?

Office
1001 W 10th St
4TH floor
Indianapolis, IN 46202
Phone+1 317-630-7979

Fax+1 317-630-2668

Education & Training

University of California (San Francisco)Fellowship, Behavioral Neurology, 2005 - 2007
Mayo Clinic College of Medicine and Science (Rochester)Chief Residency, Neurology, 2004 - 2005
Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 2002 - 2005
Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 2001 - 2002
Indiana University School of MedicineClass of 2001

Certifications & Licensure

CA State Medical License 2005 - Present
IN State Medical License 2008 - 2025
MN State Medical License 2002 - 2005
AZ State Medical License 2002 - 2004
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Fellow American Academy of Neurology, 2014
Medical Honor Society Alpha Omega Alpha (AOA), 2000

Clinical Trials

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 Start of enrollment: 2012 Dec 01
Recruiting
Phase 2, Phase 3

Publications & Presentations

PubMed

Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagement.
Dorene M Rentz, Paul S Aisen, Alireza Atri, Janice Hitchcock, Michael Irizarry
Alzheimer's & Dementia. 2024-11-01
39 citations
Expectations and clinical meaningfulness of randomized controlled trials.
Ronald C Petersen, Paul S Aisen, J Scott Andrews, Alireza Atri, Brandy R Matthews
Alzheimer's & Dementia. 2023-06-01
3 citations
Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019).
J Scott Andrews, Urvi Desai, Noam Y Kirson, Brandy R Matthews
Alzheimer's & Dementia. 2023-05-17

Press Mentions

The Elixir Factor Podcast's Debut SeasonApril 7th, 2022